vs
Side-by-side financial comparison of ALBANY INTERNATIONAL CORP (AIN) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
ALBANY INTERNATIONAL CORP is the larger business by last-quarter revenue ($321.2M vs $164.7M, roughly 2.0× PTC THERAPEUTICS, INC.). ALBANY INTERNATIONAL CORP runs the higher net margin — 4.3% vs -82.0%, a 86.3% gap on every dollar of revenue. On growth, ALBANY INTERNATIONAL CORP posted the faster year-over-year revenue change (12.0% vs -22.7%). ALBANY INTERNATIONAL CORP produced more free cash flow last quarter ($51.4M vs $-36.6M). Over the past eight quarters, ALBANY INTERNATIONAL CORP's revenue compounded faster (1.2% CAGR vs -11.5%).
Albany International Corp is a global advanced materials and industrial technology company. It operates two core segments: Machine Clothing producing custom engineered fabrics for paper and other industrial manufacturing processes, and Engineered Composites developing high-performance composite components primarily for the aerospace and defense sectors, serving customers across North America, Europe, Asia and other global regions.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
AIN vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $321.2M | $164.7M |
| Net Profit | $13.9M | $-135.0M |
| Gross Margin | 31.1% | — |
| Operating Margin | 9.3% | -43.3% |
| Net Margin | 4.3% | -82.0% |
| Revenue YoY | 12.0% | -22.7% |
| Net Profit YoY | -21.5% | -104.8% |
| EPS (diluted) | $0.56 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $321.2M | $164.7M | ||
| Q3 25 | $261.4M | $211.0M | ||
| Q2 25 | $311.4M | $178.9M | ||
| Q1 25 | $288.8M | $1.2B | ||
| Q4 24 | $286.9M | $213.2M | ||
| Q3 24 | $298.4M | $196.8M | ||
| Q2 24 | $332.0M | $186.7M | ||
| Q1 24 | $313.3M | $210.1M |
| Q4 25 | $13.9M | $-135.0M | ||
| Q3 25 | $-97.8M | $15.9M | ||
| Q2 25 | $9.2M | $-64.8M | ||
| Q1 25 | $17.4M | $866.6M | ||
| Q4 24 | $17.7M | $-65.9M | ||
| Q3 24 | $18.0M | $-106.7M | ||
| Q2 24 | $24.6M | $-99.2M | ||
| Q1 24 | $27.3M | $-91.6M |
| Q4 25 | 31.1% | — | ||
| Q3 25 | -19.1% | — | ||
| Q2 25 | 31.3% | — | ||
| Q1 25 | 33.4% | — | ||
| Q4 24 | 31.5% | — | ||
| Q3 24 | 30.3% | — | ||
| Q2 24 | 33.9% | — | ||
| Q1 24 | 34.7% | — |
| Q4 25 | 9.3% | -43.3% | ||
| Q3 25 | -44.6% | 1.4% | ||
| Q2 25 | 7.2% | -19.5% | ||
| Q1 25 | 9.8% | 82.5% | ||
| Q4 24 | 8.5% | -76.2% | ||
| Q3 24 | 8.4% | -27.7% | ||
| Q2 24 | 12.9% | -21.5% | ||
| Q1 24 | 12.4% | -21.6% |
| Q4 25 | 4.3% | -82.0% | ||
| Q3 25 | -37.4% | 7.5% | ||
| Q2 25 | 2.9% | -36.3% | ||
| Q1 25 | 6.0% | 73.7% | ||
| Q4 24 | 6.2% | -30.9% | ||
| Q3 24 | 6.0% | -54.2% | ||
| Q2 24 | 7.4% | -53.1% | ||
| Q1 24 | 8.7% | -43.6% |
| Q4 25 | $0.56 | $-1.63 | ||
| Q3 25 | $-3.37 | $0.20 | ||
| Q2 25 | $0.31 | $-0.83 | ||
| Q1 25 | $0.56 | $10.04 | ||
| Q4 24 | $0.57 | $-0.85 | ||
| Q3 24 | $0.57 | $-1.39 | ||
| Q2 24 | $0.79 | $-1.29 | ||
| Q1 24 | $0.87 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $112.3M | $1.9B |
| Total DebtLower is stronger | $455.7M | — |
| Stockholders' EquityBook value | $726.2M | $-205.3M |
| Total Assets | $1.7B | $2.9B |
| Debt / EquityLower = less leverage | 0.63× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $112.3M | $1.9B | ||
| Q3 25 | $108.3M | $1.7B | ||
| Q2 25 | $106.7M | $2.0B | ||
| Q1 25 | $119.4M | $2.0B | ||
| Q4 24 | $115.3M | $1.1B | ||
| Q3 24 | $127.2M | $1.0B | ||
| Q2 24 | $116.4M | $1.1B | ||
| Q1 24 | $125.4M | $884.8M |
| Q4 25 | $455.7M | — | ||
| Q3 25 | $480.6M | — | ||
| Q2 25 | $444.7M | — | ||
| Q1 25 | $416.4M | — | ||
| Q4 24 | $318.5M | — | ||
| Q3 24 | $362.2M | — | ||
| Q2 24 | $377.1M | — | ||
| Q1 24 | $439.1M | — |
| Q4 25 | $726.2M | $-205.3M | ||
| Q3 25 | $739.3M | $-155.8M | ||
| Q2 25 | $888.6M | $-206.5M | ||
| Q1 25 | $900.0M | $-185.8M | ||
| Q4 24 | $943.5M | $-1.1B | ||
| Q3 24 | $991.0M | $-1.1B | ||
| Q2 24 | $967.5M | $-980.2M | ||
| Q1 24 | $967.5M | $-893.9M |
| Q4 25 | $1.7B | $2.9B | ||
| Q3 25 | $1.7B | $2.6B | ||
| Q2 25 | $1.7B | $2.6B | ||
| Q1 25 | $1.7B | $2.7B | ||
| Q4 24 | $1.6B | $1.7B | ||
| Q3 24 | $1.8B | $1.8B | ||
| Q2 24 | $1.8B | $1.9B | ||
| Q1 24 | $1.8B | $1.8B |
| Q4 25 | 0.63× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.50× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 0.34× | — | ||
| Q3 24 | 0.37× | — | ||
| Q2 24 | 0.39× | — | ||
| Q1 24 | 0.45× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.7M | $-34.3M |
| Free Cash FlowOCF − Capex | $51.4M | $-36.6M |
| FCF MarginFCF / Revenue | 16.0% | -22.3% |
| Capex IntensityCapex / Revenue | 6.9% | 1.4% |
| Cash ConversionOCF / Net Profit | 5.31× | — |
| TTM Free Cash FlowTrailing 4 quarters | $82.6M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $73.7M | $-34.3M | ||
| Q3 25 | $43.9M | $-66.3M | ||
| Q2 25 | $32.7M | $-58.3M | ||
| Q1 25 | $2.1M | $870.1M | ||
| Q4 24 | $78.5M | $-30.0M | ||
| Q3 24 | $47.0M | $-77.0M | ||
| Q2 24 | $83.4M | $-71.5M | ||
| Q1 24 | $9.6M | $70.8M |
| Q4 25 | $51.4M | $-36.6M | ||
| Q3 25 | $25.9M | $-69.7M | ||
| Q2 25 | $18.8M | $-59.6M | ||
| Q1 25 | $-13.5M | $868.4M | ||
| Q4 24 | $60.2M | $-33.8M | ||
| Q3 24 | $31.6M | $-77.5M | ||
| Q2 24 | $63.6M | $-78.8M | ||
| Q1 24 | $-17.3M | $61.2M |
| Q4 25 | 16.0% | -22.3% | ||
| Q3 25 | 9.9% | -33.1% | ||
| Q2 25 | 6.0% | -33.3% | ||
| Q1 25 | -4.7% | 73.8% | ||
| Q4 24 | 21.0% | -15.8% | ||
| Q3 24 | 10.6% | -39.4% | ||
| Q2 24 | 19.2% | -42.2% | ||
| Q1 24 | -5.5% | 29.1% |
| Q4 25 | 6.9% | 1.4% | ||
| Q3 25 | 6.9% | 1.6% | ||
| Q2 25 | 4.5% | 0.7% | ||
| Q1 25 | 5.4% | 0.1% | ||
| Q4 24 | 6.4% | 1.8% | ||
| Q3 24 | 5.2% | 0.3% | ||
| Q2 24 | 6.0% | 4.0% | ||
| Q1 24 | 8.6% | 4.6% |
| Q4 25 | 5.31× | — | ||
| Q3 25 | — | -4.17× | ||
| Q2 25 | 3.56× | — | ||
| Q1 25 | 0.12× | 1.00× | ||
| Q4 24 | 4.44× | — | ||
| Q3 24 | 2.61× | — | ||
| Q2 24 | 3.39× | — | ||
| Q1 24 | 0.35× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AIN
| Transferred At Point In Time | $176.5M | 55% |
| Engineered Composites Other | $99.3M | 31% |
| Engineered Composites ASC | $44.5M | 14% |
| Transferred Over Time | $1.0M | 0% |
PTCT
Segment breakdown not available.
